(Total Views: 237)
Posted On: 04/16/2019 9:20:35 PM
Post# of 153822

Re: ClosetInvestor #2077
don't know but it could be an extra cost for patients switching to leronlimab or using it for cancer. Don't know for sure but it is a thought. What other acquisitions do you think they might be eyeing?

